New hope for fighting tough tuberculosis strains
Disease control
Recruiting now
This study is testing a new drug, JDB0131, combined with other medicines to treat tuberculosis that is resistant to standard antibiotics. It will involve 60 patients with this hard-to-treat form of TB to see if the new combination is effective and safe over 8 weeks. The main goal…
Phase: PHASE2 • Sponsor: WestVac Biopharma Co., Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC